Mahmood Ladha
Presidente presso DOVA PHARMACEUTICALS, INC.
Posizioni attive di Mahmood Ladha
Società | Posizione | Inizio | Fine |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/01/2019 | - |
DOVA PHARMACEUTICALS, INC. | Presidente | 12/11/2019 | - |
Storia della carriera di Mahmood Ladha
Precedenti posizioni note di Mahmood Ladha
Società | Posizione | Inizio | Fine |
---|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Direttore/Membro del Consiglio | - | - |
Corporate Officer/Principal | - | - |
Formazione di Mahmood Ladha
University of South Carolina | Masters Business Admin |
Statistiche
Distribuzione geografica
Svezia | 3 |
Stati Uniti | 3 |
Posizioni
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Aziende private | 2 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Mahmood Ladha
- Esperienza